Impact of gender on bladder cancer incidence, staging, and prognosis

World Journal of Urology

Volumn 29, Issue 4, 2011, Pages 457-463

  Fajkovic, Harun ^a,b   Halpern, Joshua A ^a   Cha, Eugene K ^a   Bahadori, Atessa ^a   Chromecki, Thomas F ^a,c   Karakiewicz, Pierre I ^d   Breinl, Eckart ^b   Merseburger, Axel S ^e   Shariat, Shahrokh F ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b Karl Landsteiner Institute for Implementation of Innovative Techniques in Cardiac Surgery   (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Bladder cancer prognosis; Female; Gender; Male; Recurrence; Survival; Urothelial carcinoma

Indexed keywords

BLADDER TUMOR; CANCER STAGING; CARCINOMA; DISEASE MANAGEMENT; FEMALE; HUMAN; INCIDENCE; MALE; PATHOLOGY; PROGNOSIS; REVIEW; SEXUAL DEVELOPMENT; UROTHELIUM;

CARCINOMA; DISEASE MANAGEMENT; FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASM STAGING; PROGNOSIS; SEX CHARACTERISTICS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 79960697825     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0709-9     Document Type: Review

References (58)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60: 277-300.
2. Sievert KD, Amend B, Nagele U et al (2009) Economic aspects of bladder cancer: what are the benefits and costs? World J Urol 27: 295-300.
3. Herman MP, Svatek RS, Lotan Y, Karakiewizc PI, Shariat SF (2008) Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer. Minerva Urol Nefrol 60: 217-235.
4. Shariat SF, Karakiewicz PI, Palapattu GS, et al (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176: 2414-22 (discussion 22).
5. Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J Clin Oncol 19: 666-675.
6. Madersbacher S, Hochreiter W, Burkhard F et al (2003) Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 21: 690-696.
7. USIo Medicine (2001) Exploring the biological contributions to human health: does sex matter? J Womens Health Gend Based Med 10: 433-439.
8. Pushkar DY, Govorov AV, Matveev VB (2008) The epidemiology of bladder cancer in Russia. Scand J Urol Nephrol Suppl 218: 21-24.
9. Puente D, Malats N, Cecchini L et al (2003) Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer. Eur Urol 43: 53-62.
10. Horstmann M, Witthuhn R, Falk M, Stenzl A (2008) Gender-specific differences in bladder cancer: a retrospective analysis. Gend Med 5: 385-394.
11. Mungan NA, Aben KK, Schoenberg MP et al (2000) Gender differences in stage-adjusted bladder cancer survival. Urology 55: 876-880.
12. Mungan NA, Kiemeney LA, van Dijck JA, van der Poel HG, Witjes JA (2000) Gender differences in stage distribution of bladder cancer. Urology 55: 368-371.
13. Pou SA, Osella AR, Diaz MeP (2011) Bladder cancer mortality trends and patterns in Córdoba, Argentina (1986-2006). Cancer Causes Control 22: 407-415.
14. Tracey E, Roder D, Luke C, Bishop J (2009) Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men? BJU Int 104: 498-504.
15. Svatek RS, Shariat SF, Dinney C et al (2009) Evidence-based gender related outcomes after radical cystectomy: results of a large multicenter study (abstract #1744). J Urol 181: 629.
16. Jeldres C, Isbarn H, Capitanio U et al (2009) Gender is an important predictor of cancer-specific survival in patients with urothelial carcinoma after radical cystectomy (abstract #1761). J Urol 181: 635.
17. Datta GD, Neville B, Datta NS, Earle C (2006) Gender disparities in bladder cancer survival: An assessment of socio-demographic factors. AACR Meeting Abstracts. 2006: B38 (2006 November 1).
18. Scosyrev E, Noyes K, Feng C, Messing E (2009) Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 115: 68-74.
19. Tilki D, Reich O, Svatek RS et al (2010) Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. J Urol 183: 1757-1763.
20. Tilki D, Svatek RS, Novara G et al (2010) Stage pT0 at radical cystectomy confers improved survival: an international study of 4, 430 patients. J Urol 184: 888-894.
21. Tilki D, Svatek RS, Karakiewicz PI et al (2010) Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol 183: 87-93.
22. Liberman D, Alasker A, Sun M et al (2011) Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study. BJU Int 107: 905-911.
23. Yafi FA, Duclos M, Correa JA, Tanguay S, Aprikian AG, Cury F, Souhami L, Rajan R, Kassouf W (2011) Contemporary outcome and management of patients who had an aborted cystectomy due to unresectable bladder cancer. Urol Oncol 29(3): 309-313.
24. Brookfield KF, Cheung MC, Gomez C et al (2009) Survival disparities among African American women with invasive bladder cancer in Florida. Cancer 115: 4196-4209.
25. Lloyd-Jones D, Adams RJ, Brown TM et al (2010) Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121: e46-e215.
26. Hemelt M, Yamamoto H, Cheng KK, Zeegers MP (2009) The effect of smoking on the male excess of bladder cancer: a meta-analysis and geographical analyses. Int J Cancer 124: 412-419.
27. Hartge P, Harvey EB, Linehan WM et al (1990) Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst 82: 1636-1640.
28. McGrath M, Michaud DS, De Vivo I (2006) Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol 163: 236-244.
29. Okajima E, Hiramatsu T, Iriya K, Ijuin M, Matsushima S (1975) Effects of sex hormones on development of urinary bladder tumours in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Urol Res 3: 73-79.
30. Miyamoto H, Yang Z, Chen YT et al (2007) Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 99: 558-568.
31. Boorman GA (1977) Animal model of human disease: carcinoma of the ureter and urinary bladder. Am J Pathol 88: 251-254.
32. Imada S, Akaza H, Ami Y, Koiso K, Ideyama Y, Takenaka T (1997) Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats. Eur Urol 31: 360-364.
33. Zhuang YH, Blauer M, Tammela T, Tuohimaa P (1997) Immunodetection of androgen receptor in human urinary bladder cancer. Histopathology 30: 556-562.
34. Boorjian S, Ugras S, Mongan NP et al (2004) Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. Urology 64: 383-388.
35. Ruizeveld de Winter JA, Trapman J, Vermey M, Mulder E, Zegers ND, van der Kwast TH (1991) Androgen receptor expression in human tissues: an immunohistochemical study. J Histochem Cytochem 39: 927-936.
36. Chen F, Langenstroer P, Zhang G, Iwamoto Y, See WA (2003) Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines. J Urol 170: 2009-2013.
37. Boorjian S, Ugras S, Mongan NP et al (2004) Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. Urology 64: 383-388.
38. Tuygun C, Kankaya D, Imamoglu A et al (2011) Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression. Urol Oncol 29: 43-51.
39. Mir C, Shariat SF, van Der Kwast TH et al (2010) Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study. BJU Int. doi: 10. 1111/j. 1464-410X. 2010. 09834. x.
40. Shen SS, Smith CL, Hsieh JT et al (2006) Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer 106: 2610-2616.
41. Bolenz C, Lotan Y, Ashfaq R, Shariat SF (2009) Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder. Eur Urol 56: 1093-1095.
42. Sonpavde G, Okuno N, Weiss H et al (2007) Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma. Urology 69: 1221-1226.
43. Pelletier G (2000) Localization of androgen and estrogen receptors in rat and primate tissues. Histol Histopathol 15: 1261-1270.
44. Makela S, Strauss L, Kuiper G et al (2000) Differential expression of estrogen receptors alpha and beta in adult rat accessory sex glands and lower urinary tract. Mol Cell Endocrinol 170: 219-229.
45. Saez S, Martin PM (1981) Evidence of estrogen receptors in the trigone area of human urinary bladder. J Steroid Biochem 15: 317-320.
46. Shen SS, Smith CL, Hsieh JT et al (2006) Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer 106: 2610-2616.
47. Wolpert BJ, Amr S, Saleh DA et al (2011) Associations differ by sex for catechol-O-methyltransferase genotypes and bladder cancer risk in South Egypt. Urol Oncol [Epub ahead of print].
48. Taub DA, Hollenbeck BK, Cooper KL et al (2006) Racial disparities in resource utilization for cystectomy. Urology 67: 288-293.
49. Cárdenas-Turanzas M, Cooksley C, Kamat AM, Pettaway CA, Elting LS (2008) Gender and age differences in blood utilization and length of stay in radical cystectomy: a population-based study. Int Urol Nephrol 40: 893-899.
50. Siegrist T, Savage C, Shabsigh A, Cronin A, Donat SM (2010) Analysis of gender differences in early perioperative complications following radical cystectomy at a tertiary cancer center using a standardized reporting methodology. Urol Oncol 28: 112-117.
51. Liberman D, Lughezzani G, Sun M et al (2011) Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Urology 77: 660-666.
52. Nagele U, Anastasiadis AG, Stenzl A, Kuczyk M (2011) Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long-term oncological, functional, and quality of life results. World J Urol [Epub ahead of print].
53. Porter MP, Gore JL, Wright JL (2011) Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study. World J Urol 29: 73-77.
54. Schulman KA, Berlin JA, Harless W et al (1999) The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med 340: 618-626.
55. Johnson EK, Daignault S, Zhang Y, Lee CT (2008) Patterns of hematuria referral to urologists: does a gender disparity exist? Urology 72: 498-502 discussion -3.
56. Nielsen ME, Palapattu GS, Karakiewicz PI et al (2007) A delay in radical cystectomy of > 3 months is not associated with a worse clinical outcome. BJU Int 100: 1015-1020.
57. Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS (2009) Project UDiA. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer 115: 988-996.
58. Mallin K, David KA, Carroll PR, Milowsky MI, Nanus DM (2011) Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007). J Urol 185: 1631-1636.